12:00 AM
Jul 02, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

24sure: Phase II started

BlueGnome said investigators began a U.S. Phase II trial in about 200 patients to evaluate pre-implantation diagnosis using...

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >